Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001017062-99-000569
Filing Date
1999-03-31
Accepted
1999-03-31 00:00:00
Documents
10
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K - WATSON PHARMACEUTICALS FYE 12/31/98 10-K 207742
2 CREDIT AGREEMENT DATED FEBRUARY 3, 1999 EX-4.2 121183
3 THIRD AMENDMENT TO INDUSTRIAL REAL ESTATE LEASE EX-10.3 5618
4 LEASE AMENDMENT DATED JANUARY 4, 1984 EX-10.4 107915
5 EMPLOYMENT AGREEMENT WITH MICHAEL E. BOXER EX-10.10 27169
6 SUBSIDIARIES OF THE COMPANY EX-22.1 974
7 CONSENT OF PRICEWATERHOUSECOOPERS LLP EX-23.1 710
8 CONSENT OF DELOITTE & TOUCHE LLP EX-23.2 727
9 CONSENT OF ARTHUR ANDERSEN LLP EX-23.3 756
10 FINANCIAL DATA SCHEDULE - ARTICLE 5 EX-27.1 2085
  Complete submission text file 0001017062-99-000569.txt   477335
Mailing Address 311 BONNIE CIRCLE CORONA CA 91720
Business Address 311 BONNIE CIRCLE CORONA CA 91720 9092701400
WATSON PHARMACEUTICALS INC (Filer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13305 | Film No.: 99581522
SIC: 2834 Pharmaceutical Preparations